2m 2m 2m 2m 2m 2m 2m
BICARA THERAP (BCAX)
NASDAQ
$28.14-$0.010 (-0.04%)
Price as of Jul 13, 2026 6:18 PM EDT- $1.9BMarket Cap
- 176.52%1-Year Change
- BiotechnologyIndustry
BICARA THERAP (BCAX)
$28.14-$0.010 (-0.04%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 13.25% | 7.3M | +300,000 (+4.13%) | Mar 31, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 12.06% | 6.6M | +3.4M (+51.00%) | Mar 31, 2026 |
SIREN, L.L.C. | 10.59% | 5.8M | +586,001 (+10.10%) | Mar 31, 2026 |
VESTAL POINT CAPITAL, LP | 9.90% | 5.4M | +1.9M (+34.10%) | Mar 31, 2026 |
DEEP TRACK CAPITAL, LP | 7.42% | 4.1M | +1.4M (+35.66%) | Mar 31, 2026 |
JANUS HENDERSON GROUP PLC | 6.10% | 3.3M | +692,933 (+20.75%) | Mar 31, 2026 |
RED TREE MANAGEMENT, LLC | 5.79% | 3.2M | 0 (0.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
T. Rowe Price Small-Cap Stock Fund, Inc. | 3.98% | 2.2M | +767,156 (+35.16%) | Mar 31, 2026 |
VANGUARD INDEX FUNDS | 3.15% | 1.7M | +70,658 (+4.09%) | Mar 31, 2026 |
T. Rowe Price Equity Funds, Inc. | 2.18% | 1.2M | +427,489 (+35.73%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.72% | 944,900 | 0 (0.00%) | Apr 30, 2026 |
FRANKLIN STRATEGIC SERIES | 1.63% | 892,482 | +26,437 (+2.96%) | Apr 30, 2026 |
T. Rowe Price Small-Cap Value Fund, Inc. | 1.29% | 705,031 | +705,031 (+100.00%) | Mar 31, 2026 |
SPDR SERIES TRUST | 1.28% | 701,643 | 0 (0.00%) | Apr 30, 2026 |
Current Ownership Distribution
- Institutions316.2M (81.90%)
- Mutual Funds59.4M (15.38%)
- Insiders10.5M (2.72%)
- Other0 (0.00%)
Insider Transactions
- 2.72% (10.5M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $68.9MAmount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $142.0MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Hyep Ivan Chief Financial Officer | Exempt | Jul 08, 2026 | $0.00 | 11,592 | $0.00 | 58,992 |
Hyep Ivan Chief Financial Officer | Exempt | Jul 08, 2026 | $0.00 | 908 | $0.00 | 38,836 |
Hyep Ivan Chief Financial Officer | Exempt | Jul 08, 2026 | $47,372.50 | 12,500 | $3.79 | 157,855 |
Hyep Ivan Chief Financial Officer | Sell | Jul 08, 2026 | $650,895.71 | 22,757 | $28.60 | 135,098 |
Hyep Ivan Chief Financial Officer | Sell | Jul 08, 2026 | $131,615.96 | 4,413 | $29.82 | 130,685 |
Hyep Ivan Chief Financial Officer | Sell | Jul 08, 2026 | $25,160.29 | 830 | $30.31 | 129,855 |
Simson Jake | Award | Jun 09, 2026 | $0.00 | 19,475 | $0.00 | 19,475 |
Mazumdar-Shaw Kiran | Award | Jun 09, 2026 | $0.00 | 19,475 | $0.00 | 19,475 |
Robertson Scott M. | Award | Jun 09, 2026 | $0.00 | 19,475 | $0.00 | 19,475 |
Haviland Kate | Award | Jun 09, 2026 | $0.00 | 19,475 | $0.00 | 19,475 |
POWELL MICHAEL | Award | Jun 09, 2026 | $0.00 | 19,475 | $0.00 | 19,475 |
Raben David Chief Medical Officer | Exempt | Mar 25, 2026 | $0.00 | 5,500 | $0.00 | 47,413 |
Raben David Chief Medical Officer | Exempt | Mar 25, 2026 | $20,843.90 | 5,500 | $3.79 | 60,786 |
Raben David Chief Medical Officer | Sell | Mar 25, 2026 | $104,229.40 | 5,500 | $18.95 | 55,286 |
Hyep Ivan Chief Financial Officer | Exempt | Mar 23, 2026 | $0.00 | 9,200 | $0.00 | 48,944 |
Hyep Ivan Chief Financial Officer | Exempt | Mar 23, 2026 | $34,866.16 | 9,200 | $3.79 | 154,555 |
Hyep Ivan Chief Financial Officer | Sell | Mar 23, 2026 | $170,348.12 | 9,200 | $18.52 | 145,355 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 20, 2026 | $6,048.52 | 1,596 | $3.79 | 340,988 |
Mazumdar Claire Chief Executive Officer | Sell | Mar 20, 2026 | $30,246.27 | 1,596 | $18.95 | 339,392 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 20, 2026 | $0.00 | 1,596 | $0.00 | 176,107 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 19, 2026 | $0.00 | 6,905 | $0.00 | 177,703 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 19, 2026 | $26,168.57 | 6,905 | $3.79 | 346,297 |
Mazumdar Claire Chief Executive Officer | Sell | Mar 19, 2026 | $129,704.90 | 6,905 | $18.78 | 339,392 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 18, 2026 | $0.00 | 6,499 | $0.00 | 184,608 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 18, 2026 | $24,629.91 | 6,499 | $3.79 | 345,891 |
Mazumdar Claire Chief Executive Officer | Sell | Mar 18, 2026 | $122,414.51 | 6,499 | $18.84 | 339,392 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 09, 2026 | $0.00 | 36,766 | $0.00 | 191,107 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 09, 2026 | $139,335.79 | 36,766 | $3.79 | 376,158 |
Mazumdar Claire Chief Executive Officer | Sell | Mar 09, 2026 | $704,657.16 | 36,766 | $19.17 | 339,392 |
Mazumdar Claire Chief Executive Officer | Exempt | Mar 06, 2026 | $0.00 | 3,817 | $0.00 | 227,873 |